Month: September 2026

Independent research teams at MD Anderson Cancer Center, the University of Oulu, and the Josep Carreras Leukaemia Research Institute report that optical genome mapping (OGM) uncovers clinically significant genomic alterations missed by conventional cytogenetics, with direct implications for risk stratification across MDS, AML, and therapy-related myeloid neoplasms

SAN DIEGO, Sept. 14, 2026 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) today highlighted three new independently authored, peer-reviewed publications demonstrating the clinical utility of OGM in high-risk hematologic malignancies — myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and therapy-related myeloid neoplasms (t-MN). The studies, published in Modern Pathology, the International Journal of Cancer, and npj Precision Oncology, reinforce a growing body of evidence that OGM can detect prognostically important structural genomic alterations that elude standard karyotyping, FISH, and targeted sequencing panels.

MD Anderson Cancer Center: Chromoanagenesis by OGM defines an ultra-high-risk MDS subset.

Researchers at The University of Texas MD Anderson Cancer Center, led by Guilin Tang, PhD, used OGM to study 332 samples from subjects with MDS, identifying chromoanagenesis (CAG), a catastrophic single-event genomic restructuring process, in 15.9% of cases overall and 17.6% of newly diagnosed subjects. The study, published in Modern Pathology (Wei et al., 2026), found that:

• CAG-positive by OGM subjects had a median overall survival of just 9.9 months, significantly shorter than non-CAG subjects where median survival was not reached.
• CAG by OGM showed the potential to confer prognostic information beyond existing risk-stratification systems, potentially enabling the identification of patients for early allogeneic transplantation or TP53-targeted clinical trials.

University of Oulu: Cryptic structural variants uncovered in “normal karyotype” AML.

A separate study from the University of Oulu and collaborators, led by Tuomo Mantere, PhD, used OGM to analyze 48 samples of cytogenetically normal AML (CN-AML) — a subgroup that appears unremarkable on standard karyotyping but is clinically heterogeneous. Published in the International Journal of Cancer (Turtinen et al., 2026), the study found that:

• OGM detected clinically relevant structural variants or copy-neutral loss-of-heterozygosity in 46% of cases classified as “normal” by conventional karyotyping.
• Recurrent alterations included KMT2A partial tandem duplications (10% of cases), RUNX1 disruptions, NF1 deletions, and a novel putative FOXP1:EYA2 fusion not previously reported in the literature.
• Subjects with OGM-detected abnormalities had significantly worse overall survival than those without (p = 0.005).

Josep Carreras Leukaemia Research Institute: OGM refines risk in therapy-related neoplasms and younger MDS.

A multicenter Spanish study led by Mar Mallo, PhD, and Francesc Solé, PhD, at the Josep Carreras Leukaemia Research Institute in collaboration with a Spanish hospital network applied OGM to two clinically distinct: 48 subjects with therapy-related myeloid neoplasms (t-MN) and 65 subjects with younger-onset MDS (yMDS, age ≤60). Published in npj Precision Oncology (Mestre et al., 2026), the study found that:

• OGM was interpretable in 100% of samples, including all 8 cases where conventional banding analysis (CBA) failed due to lack of dividing cells, and identified 134 additional genomic alterations.
• OGM refined cytogenetic classification in 52.0% of karyotypically abnormal cases and detected clinically relevant structural alterations in 9.8% of cases with a normal karyotype, including reclassification of subjects into the therapeutically relevant MDS with isolated 5q- category.
• OGM-defined genomic complexity was independently associated with overall survival; chromoanagenesis emerged as the strongest independent predictor of inferior survival in multivariable analysis (HR 9.26), exceeding even TP53 mutation status.
• Integrating OGM findings into IPSS-R and IPSS-M scoring shifted 16.7% of t-MN and up to 12.8% of yMDS subjects into higher-risk prognostic categories, which could have implications for treatment planning, including identification of biallelic TP53 inactivation.

Key highlights across all three studies:

• Three independent academic centers, spanning the U.S., Finland, and Spain, each show the potential for OGM to identify clinically actionable genomic complexity that conventional cytogenetic workups miss.
• All three studies link OGM findings directly to overall and/or disease-specific survival.
• Findings support a potential role for OGM in refining prognostication beyond IPSS-R/IPSS-M and ELN2022 classification systems, including in patients who otherwise appear lower-risk by standard testing, and in cases where conventional karyotyping fails outright due to lack of dividing cells.
• Across all three cohorts, chromoanagenesis and TP53 disruption consistently emerge as markers of a biologically distinct, ultra-high-risk disease subset best captured by genome-wide structural variant detection.

“These three independent studies, spanning MDS, AML, and therapy-related myeloid neoplasms, all point to the same conclusion: a meaningful fraction of high-risk genomic complexity in myeloid malignancies is simply invisible to conventional karyotyping,” said Al Luderer, PhD, chairman and interim chief executive officer of Bionano. “As OGM adoption continues to expand, we expect to see more of this kind of evidence connecting structural variant detection directly to potential patient outcomes and treatment decisions.”

Turtinen et al.: https://doi.org/10.1002/ijc.70548
Wei et al.: https://doi.org/10.1016/j.modpat.2026.101031
Mestre et al.: https://doi.org/10.1038/s41698-026-01671-z

About Bionano Genomics
Bionano is a provider of genome analysis solutions that enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through optical genome mapping (OGM) solutions, diagnostic services, and software. Bionano offers OGM solutions for applications across basic, translational, and clinical research, as well as an industry-leading, platform-agnostic genome analysis software solution and nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. Through its Bionano Laboratories business, the Company also offers OGM-based diagnostic testing services.

For more information, visit www.bionano.com or www.bionanolaboratories.com.
Bionano’s products are for research use only and not for use in diagnostic procedures.

Forward-Looking Statements of Bionano Genomics
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations or financial condition, business strategy and plans, and objectives of management for future operations, are forward-looking statements. Words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) convey uncertainty of future events or outcomes and are intended to identify forward-looking statements. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things: our expectations regarding market adoption of our products; our commercial prospects and future financial and operating results; and the utility of OGM for the applications referenced in this press release. Each of these forward-looking statements involves risks and uncertainties. Accordingly, investors and prospective investors are cautioned not to place undue reliance on these forward-looking statements as they involve inherent risk and uncertainty (both general and specific) and should note that they are provided as a general guide only and should not be relied on as an indication or guarantee of future performance. There are a number of important factors that could cause the actual results to differ materially from those expressed in any forward-looking statement made by us. These factors include, but are not limited to: our ability to improve our margins, extend our cash runway and reach a potential pathway to profitability; our ability to continue as a going concern as disclosed in our filings with the SEC, which requires us to manage costs and obtain significant additional financing to fund our strategic plans and commercialization efforts; our ability to execute on our strategy and achieve our objectives; the impact and utility of our cost savings initiative and our recent financing; our ability to continue to drive OGM (as defined above) adoption by potential customers for routine use in genomic analysis; the impact, or lack thereof, of Category I CPT codes to accelerate or increase the adoption of OGM; continued research, presentations and publications involving OGM and its utility compared to traditional cytogenetics and our technologies; the impact of our Stratys™ system and VIA™ software to increase throughput and simplify analysis of OGM data; our ability to drive adoption of OGM and our technology solutions; our ability to further deploy new products and applications for our technology platforms; our expectations and beliefs regarding future growth of the business and the markets in which we operate; our ability to consummate any strategic alternatives including the risk that if we fail to obtain additional financing we may seek relief under applicable insolvency laws; the size and growth potential of the markets for our products, and our ability to serve those markets; the rate and degree of market acceptance of our products; our ability to manage the growth of our business and integrate acquired businesses; the fact that we are limited to “research use only” with respect to many of the materials and components used in our consumable products including our assays; our ability to expand our commercial organization to address effectively existing and new markets that we intend to target; the impact from future regulatory, judicial, and legislative changes or developments in the U.S. and foreign countries; our ability to compete effectively in a competitive industry; the introduction of competitive technologies or improvements in existing technologies and the success of any such technologies; the performance of our third-party contract sales organizations, suppliers and manufacturers; our ability to attract and retain key scientific or management personnel; the accuracy of our estimates regarding expenses, future revenues, reimbursement rates, capital requirements and needs for additional financing; the impact of adverse geopolitical and macroeconomic developments, such as recent and future bank failures, ongoing international conflicts, and related sanctions, regional or global pandemics, inflation, tariffs, increased cost of goods, supply chain issues, and global financial market conditions; on our business and operations, as well as the business or operations of our suppliers, customers, manufacturers, research partners and other third parties with whom we conduct business and our expectations with respect to the duration of such impacts and the resulting effects on our business; our ability to realize the anticipated benefits and synergies of our prior and any future acquisitions or other strategic transactions; our ability to attract collaborators and strategic partnerships; and the risks and uncertainties associated with our business and financial condition in general, including the risks and uncertainties described in our filings with the Securities and Exchange Commission (“SEC”), including, without limitation, our Annual Report on Form 10-K for the year ended December 31, 2025, any subsequently filed Quarterly Reports on Form 10-Q and in other filings subsequently made by us with the SEC. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management’s assumptions and estimates as of such date. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise, except as may be required by law.

CONTACT

Investor Relations:
Webb Campbell
Gilmartin Group
+1 (415) 520-5817

LAVAL, Québec, Sept. 14, 2026 (GLOBE NEWSWIRE) — Savaria Corporation (“Savaria”) (TSX: SIS) one of the global leaders in the accessibility industry, announces today that its Board of Directors has approved an increase to the Corporation’s monthly dividend, raising it to 4.916 cents (0.04916 $) per common share. On an annual basis, this represents an increase of three cents ($0.03) or 5.36%, raising the dividend to 59 cents ($0.59) per common share. This increase will apply to the dividends payable monthly starting on October 9, 2026, to shareholders of record of the Corporation at the close of business on September 30, 2026. This is an eligible dividend within the meaning of the Income Tax Act (Canada).

A Word from the Executive Chairman

“As a result of our financial performance in 2025 and for the first six months of 2026, I am pleased to announce an increase in our dividend. This dividend increase reflects our confidence in continuing to deliver strong profitability in the coming years, while maintaining ample balance sheet flexibility by paying down debt and having the ability to invest in growth opportunities as they arise. So far in 2026 we have invested or have committed to invest approximately $40M by year end across acquisitions, including Vipal S.p.A. in Italy and Baxter in Texas, as well as the expansion of our manufacturing plant in Greenville, South Carolina.”, said Marcel Bourassa, Executive Chairman.

About Savaria Corporation

Savaria Corporation (corp.savaria.com) is one of the global leaders in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as elevators for home and commercial use, stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and dumbwaiters. In addition, Savaria manufactures and markets a comprehensive selection of pressure management products, medical beds, as well as an extensive line of medical equipment and solutions for the safe movement of patients, such as transfer, lifting and repositioning aids. The Corporation operates a sales network of dealers worldwide and direct sales offices in North America, Europe (UK, Netherlands, Switzerland, Italy, Germany, Poland and Czech Republic) and Australia. Savaria employs approximately 2,550 people globally and its plants are located across Canada, the United States, Mexico, Europe and China.

For further information:

Sébastien Bourassa President and CEO 1. 800.661.5112  sb@savaria.com

Stephen Reitknecht, CPA, CA Chief Financial Officer 1.800.661.5112, ext. 3370 sreitknecht@savaria.com

Facebook : https://www.facebook.com/savariabettermobility
Instagram :https://www.instagram.com/savariacorp/
LinkedIn: https://ca.linkedin.com/company/savaria

WEST PALM BEACH, Fla., Sept. 14, 2026 (GLOBE NEWSWIRE) — Chatham Lodging Trust (NYSE: CLDT), a lodging real estate investment trust (REIT) that invests in upscale, extended-stay hotels and premium-branded, select-service hotels, today announced the appointment of Liam Brown to the company’s board of trustees, effective immediately. Brown will serve as an independent director.

Brown formerly was group president, United States and Canada of Marriott International, Inc., (“Marriott”) from January 2021 until his retirement in June 2026. In that role, he was responsible for the financial management and leadership of Marriott’s lodging operations in North and South America, comprising more than 6,000 hotels and a workforce of approximately 160,000 associates. Prior to this role, Brown served as the president and managing director of Europe of Marriott from 2018 to 2019, followed by group president of Europe, Middle East & Africa of Marriott in 2020. He joined Marriott in 1989 and served as president for franchising, owner services and managed by Marriott select brands, North America, from 2012 to 2018. Brown held other key positions with Marriott, including chief operations officer for the Americas for select service & extended stay lodging and owner & franchise services, as well as senior vice president and executive vice president of development for Marriott’s select service & extended stay lodging products.

Jeffrey H. Fisher, Chatham’s chairman of the board and chief executive officer, emphasized, “We have worked with Liam over the past 30 years and are excited to bring his extensive lodging expertise to our board. His resume speaks for itself, and his addition to the board brings substantial insights from both an operations and franchisor/franchisee relationship perspective that will be very helpful as we enhance shareholder value through continued focus on maximizing operating results and critical analysis of capital allocation decisions.”

Brown currently serves on the board of EPR Properties (NYSE: EPR), a publicly traded diversified experiential net lease REIT, where he is a member of the Compensation & Human Capital Committee (chair) and the Nominating/Company Governance Committee. He also serves on the Executive Committee of the American Hotel and Lodging Association. He holds a Hotel Diploma and Business Degree from the Dublin Institute of Technology, Trinity College and earned his Master of Business Administration from the Robert H. Smith School of Management at the University of Maryland.

About Chatham Lodging Trust

Chatham Lodging Trust is a self-advised, publicly-traded real estate investment trust focused primarily on investing in upscale, extended-stay hotels and premium-branded, select-service hotels. Additional information about Chatham may be found at chathamlodgingtrust.com.

Included in this press release are certain “non-GAAP financial measures,” within the meaning of Securities and Exchange Commission (SEC) rules and regulations, that are different from measures calculated and presented in accordance with GAAP (generally accepted accounting principles). The company considers the following non-GAAP financial measures useful to investors as key supplemental measures of its operating performance: (1) FFO, (2) Adjusted FFO, (3) EBITDA, and (4) Adjusted EBITDA. These non-GAAP financial measures could be considered along with, but not as alternatives to, net income or loss, cash flows from operations or any other measures of the company’s operating performance prescribed by GAAP.

Contact:
Dennis Craven (Company)	Chris Daly (Media)
Chief Operating Officer	DG Public Relations
(561) 227-1386	(703) 864-5553

New suite of professionally constructed model portfolios brings asset selection, sizing, diversification, and rebalancing into a single framework for financial advisors

STAMFORD, Conn., Sept. 14, 2026 (GLOBE NEWSWIRE) — Grayscale Investments^®, the world’s largest digital asset-focused investment platform*, today announced the launch of Grayscale Model Portfolios, a new suite of professionally constructed model portfolios that provide suggested allocations across the digital asset ecosystem, with each model designed around a distinct investment objective. The launch expands Grayscale’s advisor-focused offering with a portfolio-based approach to digital asset investing.

“Advisors are increasingly looking for ways to bring digital assets into client portfolios without having to build and maintain allocations asset by asset,” said Laurie Katz, Global Head of Distribution at Grayscale. “Grayscale Model Portfolios are designed to meet that need, combining our portfolio construction expertise with more than a decade of digital asset experience so advisors can offer clients thoughtfully constructed digital asset exposure through a single, familiar framework.”

Each Grayscale Model Portfolio combines multiple digital asset exchange traded products within a single strategy, giving advisors a more efficient way to access the breadth of the asset class than constructing and managing individual positions. Asset selection, position sizing, diversification, and rebalancing are incorporated into each model’s methodology, helping advisors implement and maintain digital asset exposure within a consistent portfolio framework.

Grayscale Model Portfolios launch with four strategies, each designed around a distinct investment objective:

• Digital Assets Core Plus: Build a foundational digital asset allocation. Core Plus is designed to provide broad exposure to established digital assets, combining Bitcoin (BTC) and Ethereum (ETH) with select leading assets such as Solana (SOL) and Chainlink (LINK). The portfolio is market-cap weighted, rebalanced quarterly, and subject to a 40% weighting cap per asset.
• Digital Assets Leaders: Access the leaders of the digital asset market. Digital Assets Leaders is designed to provide exposure to the five largest eligible digital assets held in single-asset Grayscale ETPs. As market leadership evolves, the portfolio adjusts to maintain exposure to leading assets. The portfolio is market-cap weighted, rebalanced quarterly, and subject to a 40% weighting cap per asset.
• Digital Assets Next Gen: Expand beyond core digital assets. Digital Assets Next Gen is a portfolio of crypto assets providing exposure to established and emerging digital assets, excluding Bitcoin, across the broader digital asset economy. The portfolio holds up to 10 eligible assets, is market-cap weighted, rebalanced quarterly, and subject to a 40% weighting cap per asset.
• Digital Assets Infrastructure: Access the protocols powering digital asset innovation. Digital Assets Infrastructure provides exposure to digital assets underlying protocols supporting smart contracts, tokenization, and other foundational applications across the digital asset economy. The portfolio is market-cap weighted, rebalanced quarterly, and subject to a 40% weighting cap per asset.

Grayscale Advisors, LLC will deliver Grayscale Model Portfolios directly to financial platforms, which make the models available to advisors for implementation in client accounts. Advisors implementing the models retain full discretion over how allocations are applied to their clients’ accounts, allowing digital asset exposure to be managed alongside the rest of a client’s portfolio. For additional information about Grayscale Model Portfolios, please visit: https://www.grayscale.com/model-portfolios

About Grayscale
Grayscale is the world’s largest digital asset-focused investment platform with a mission to make digital asset investing simpler and open to all investors. Founded in 2013, Grayscale has been at the forefront of bringing digital assets into the mainstream. The firm has a long history of firsts, including launching the first Bitcoin and Ethereum exchange traded products in the United States. Grayscale continues to pioneer the asset class by providing investors, advisors, and institutional allocators with access to a broad range of digital assets through a comprehensive suite of investment products spanning ETFs, private funds, and diversified strategies. For more information, please follow @Grayscale or visit grayscale.com.

Media Contact
press@grayscale.com

Client Contact
866-775-0313
info@grayscale.com

*Largest digital asset-focused investment platform based on assets under management (“AUM”) as of 6/30/2026. For other companies in this category, AUM is considered as of most recent public disclosure.

This information should not be relied upon as research, investment advice, or a recommendation by Grayscale regarding (i) the funds, (ii) the use or suitability of the model portfolios or (iii) any security in particular. Only an investor and their financial professional know enough about their circumstances to make an investment decision.

Carefully consider the funds’ investment objectives, risk factors, and charges and expenses before investing. This and other information can be found in the funds’ prospectuses or, if available, the summary prospectuses, which may be obtained by visiting Grayscale.com. Read the prospectus carefully before investing.

Investing involves a high degree of risk and heightened volatility, including possible loss of principal. An investment is not suitable for all investors, may be deemed speculative and is not intended as a complete investment program. An investment should be considered only by persons who can bear the risk of total loss associated with an investment. An investment in any Grayscale product is not a direct investment in any cryptocurrency.

The strategies discussed are strictly for illustrative and educational purposes and are not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. There is no guarantee that any strategies discussed will be effective.

Grayscale Advisors, LLC (“Grayscale Advisors” or the “Firm”) also provides model portfolios to financial intermediaries (“Model Recipients”), which determine whether the models are appropriate for their clients and implement them at their own discretion. Grayscale Advisors does not exercise investment discretion over Model Recipient client accounts, charge Model Recipients or their clients a direct advisory fee, have a direct advisory relationship with those clients, or owe them a fiduciary duty. Model Recipients are responsible for suitability and best-interest determinations, implementation, trade execution and client reporting. The models are not tailored to individual Model Recipients or their clients.

Grayscale Advisors, a registered investment adviser, manages Model Portfolio Strategies that invest in digital asset exchange-traded products (“ETPs”), including ETPs sponsored by its affiliate, Grayscale Investments Sponsors, LLC (“GSIS”). Initial capital for the Model Portfolio Strategies was provided by Grayscale Operating, LLC (“GSO”), the Firm’s parent company. Foreside Fund Services, LLC is the marketing agent for Grayscale ETPs. In connection with the Grayscale ETPs, which may be included in the Model Portfolio Strategies, GSIS, an affiliate, receives Sponsor’s Fees and certain fees related to staking.
Foreside Fund Services, LLC is the distributor and Grayscale Advisors, LLC (“GSA”) is the adviser of Grayscale ETFs. Foreside is not related to GSA or its affiliates.

© 2026 Grayscale. All trademarks, service marks and/or trade names (e.g., G™, GRAYSCALE®, GRAYSCALE CRYPTO SECTORS™, and GRAYSCALE INVESTMENTS®) are owned and/or registered by Grayscale.

Forum Expands Ecosystem Readiness Alongside Groundbreaking Pre-Standard ISAC and Live Sports Companion Milestones

NEW YORK, Sept. 14, 2026 (GLOBE NEWSWIRE) — Verizon today announced a major acceleration in the development of next-generation wireless architectures with the formal expansion of the Verizon 6G Innovation Forum (6GIF). Nine industry heavyweights—Amazon Web Services (AWS), Cisco, Intel, Keysight Technologies, MediaTek, NVIDIA, Palo Alto Networks, Rohde & Schwarz and VIAVI Solutions—have officially joined the forum, launched last year to establish an open, diversified, and resilient 6G ecosystem and develop foundational 6G technologies.

“By expanding our Innovation Forum and refining live edge-AI trials today, we are ensuring the AI-native 6G network is built from day one to scale 5G Advanced capabilities and translate these next-generation technologies into meaningful, real-world experiences for our customers,” said Yago Tenorio, Chief Technology Officer and Senior Vice President of Technology Development at Verizon. “With 6G, our collaborative objective is fundamentally bottom-up and use-case-driven. We are designing the next generation of connectivity with a specific target already in mind: enabling and scaling AI workloads and the massive AI ecosystem—particularly the emerging class of AI-enabled wearables like untethered smart glasses, as well as pioneering Integrated Sensing and Communication (ISAC) technologies.”

The Verizon 6G Innovation Forum which includes founding members Ericsson, Samsung, Nokia, Meta, and Qualcomm Technologies focuses on unlocking the full potential of 6G by trialing new use cases, testing new spectrum bands and bandwidth, and ensuring global alignment with global standards bodies like the 3GPP. The arrival of the nine new members injects critical multi-disciplinary capabilities across cloud services, advanced silicon and accelerated computing, independent automated test emulation, network security and immersive device graphics simulation.

Pioneering Real-World ISAC Trials with Founding Partners
To move 6G from theoretical discussion into practical reality, Verizon highlighted recent successful field trials with founding members Samsung and Qualcomm targeting Integrated Sensing and Communication (ISAC) use cases. ISAC essentially transforms the cellular network into a massive, distributed radar-like sensor without the need for physical cameras. Using 5G Advanced capabilities, the companies explored how ISAC could support public safety, environmental awareness and event management, creating a path to evolve these capabilities with 6G.

• Crowd Density Detection Demo with Samsung: Staged live at a major international soccer celebration in Dallas, Texas, this milestone represented the industry’s first AI-powered ISAC trial on a virtualized Radio Access Network (vRAN) for crowd detection. Using a single 5G base station and 40MHz of CBRS spectrum, the network tracked the raw radio variations from six localized Samsung Galaxy smartphones. Samsung’s AI RAN and edge AI platform, Network in a Server (NIS) then analyzed these ambient wireless signal changes to generate real-time crowd-density heatmaps on commercial phones and a tablet. The trial validated how network-native sensing can enable real-time intelligence for large-scale events, which could allow event organizers to monitor spectator flows in real-time, streamline gate operations, reduce concession line wait times, and proactively address overcrowding risks.¹
• Drone and Vehicle Safety Tracking Demo with Qualcomm: Conducted at Qualcomm’s San Diego campus, this trial demonstrated the network’s ability to seamlessly multitask. Utilizing 100 to 400MHz of millimeter-wave spectrum and four synchronized Transmission and Reception Points (TRPs), the system successfully mapped and tracked the position and velocity of an airborne target and moving ground vehicles. Crucially, the network maintained radar-like tracking of the drone while simultaneously providing uninterrupted, high-speed 5G Standalone (SA) mobile communications to a phone user on the ground. This highlights 6G’s potential to provide the foundational, secure tracking infrastructure required for future autonomous drone safety.

Trialing an AI Sports Companion Application
Further driving its strategy of building infrastructure around the applications of tomorrow, Verizon showcased a prototype of an AI Sports Companion application. Next-generation, AI-native devices and wearables like smart glasses will demand ultra-low latency and a more balanced uplink-downlink model as the glasses will generate as much uplink data as downloading content.

Powered directly by the Verizon Edge Network, this research prototype application showed how that architectural shift could translate into a premium fan experience. Wearing Meta AI glasses, users could enjoy a game in a stadium or at home completely hands-free without looking down at a phone. Utilizing an ultra-fast edge network with a locally optimized Small Language Model (SLM), a NVIDIA DGX Spark and statistics from SportsDataIO, the application allowed users to verbally ask for real-time player statistics, live score interpretations, or game-winning probabilities, receiving instant, spoken answers right in their ear. The prototype was designed to explore how future technology could eliminate the friction of juggling multiple apps and keep fans immersed in the game while providing deep, real-time insights.

The Path to 6G Deployment
Looking forward, Verizon 6GIF members will continue to share learnings from future ecosystem demonstrations involving ISAC, digital twins, robotics, AI and advanced wearables. Verizon views the 2028 Summer Olympics in Los Angeles as the ultimate interim proving ground on the road to commercial 6G deployment.

With Verizon’s dedicated 6G Lab already established directly in Los Angeles, the host city will serve as a live, real-world stage to stress-test the massive capacity demands and early use cases of the AI-native era, delivering practical user experiences that prove and validate the next generation of wireless technology.

This announcement was originally published by Verizon. Read the original press release.

Media contact:
Chris Ashraf
Christina.moon.ashraf@verizon.com
201-320-4259

¹_{The crowd sensing demo measures crowd density which is the number of people in a given area, at any given time. Individual users or objects are not identified. No information is obtained about the identity of the individuals.}

_{Verizon Communications Inc. (NYSE, Nasdaq: VZ) powers and empowers how its millions of customers live, work and play, delivering on their demand for mobility, reliable network connectivity and security. Headquartered in New York City, serving countries worldwide and nearly all of the Fortune 500, Verizon generated revenues of $138.2 billion in 2025. Verizon’s world-class team never stops innovating to meet customers where they are today and equip them for the needs of tomorrow. For more, visit verizon.com or find a retail location at verizon.com/stores}

_{VERIZON’S ONLINE MEDIA CENTER: News releases, stories, media contacts and other resources are available at verizon.com/news. News releases are also available through an RSS feed. To subscribe, visit www.verizon.com/about/rss-feeds/.}

Commissioning of Carbon Dioxide Degassing System Ahead of Schedule Marks Key Milestone in Capacity Enhancement Program

ENGLEWOOD, Colo., Sept. 14, 2026 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ: GEVO) today announced continued progress on the debottlenecking initiative at its Gevo North Dakota (“GND”) facility in Richardton, North Dakota, including the successful commissioning of a new beer degassing system ahead of schedule which will capture and sequester more CO₂. The debottlenecking will result in a 10-15 percent increase in GND output and returns and closely follows the successful commissioning of a steam turbine project in August.

The debottlenecking program is designed to enhance operating efficiency and increase production capacity at GND as the facility advances toward its targeted production capacity of approximately 75 million gallons per year. The project includes three primary upgrades:

• Addition of a third liquefaction tank to expand capacity and improve the yield of corn starch to sugars
• Addition of a fifth fermenter to increase fermentation residence time to enable the production of more ethanol and CO₂
• Installation of a beer degassing system to capture and sequester additional CO₂ from the ethanol process

The CO₂ beer degassing system is currently being commissioned, several weeks earlier than originally planned. This equipment will enable GND to increase CO₂ recovery, unlock distillation capacity, and lower the facility CI score.

“This milestone represents another step forward in our efforts to optimize GND and unlock additional value from an already strong operating asset,” said Gevo Chief Executive Officer Paul Bloom. “Our debottlenecking program is focused on practical, high-return improvements that enhance production efficiency, carbon capture performance and overall facility economics.”

Construction and installation activities associated with liquefaction and fermentation continue to progress on schedule and both assets are expected to be operational by the end of 2026.

GND also recently completed the commissioning of a steam turbine project. The project lowers the plant energy consumption by optimizing the steam usage inside the plant while lowering the amount of purchased electricity. This project was already started prior to Gevo’s acquisition of the facility and was successfully integrated into plant operations in August.

The steam turbine and debottlenecking project are both examples of Gevo’s ability to unlock process capacity while operating safely and efficiently. These projects are laying the groundwork for the planned 75Mgpy expansion of GND which is anticipated to approximately double the output and returns from GND and is expected to be completed in 2028.

About Gevo

Gevo is a next-generation diversified energy company committed to fueling America’s future with cost-effective, drop-in fuels that contribute to energy security, abate carbon, and strengthen rural communities to drive economic growth. Gevo’s innovative technology can be used to make a variety of renewable products, including sustainable aviation fuel (SAF), motor fuels, chemicals, and other materials that provide U.S.-made solutions. Gevo’s business model includes developing, financing, and operating production facilities that create jobs and revitalize communities. Gevo owns and operates an ethanol plant with an adjacent carbon capture and storage (CCS) facility and Class VI carbon-storage well. Gevo also owns and operates one of the largest dairy-based renewable natural gas (RNG) facilities in the United States, turning by-products into clean, reliable energy. Additionally, Gevo developed the world’s first production facility for specialty alcohol-to-jet (ATJ) fuels and chemicals operating since 2012. Gevo is currently developing the world’s first large-scale ATJ facility to be co-located at our North Dakota site. Gevo’s market-driven “pay-for-performance” approach regarding carbon and other sustainability attributes helps deliver value to our local economies. Through its Verity subsidiary, Gevo provides transparency, accountability, and efficiency in tracking, measuring, and verifying various attributes throughout the supply chain. By strengthening rural economies, Gevo is working to secure a self-sufficient future and to make sure value is brought to the market.

For more information, please visit www.gevo.com.

Forward-Looking Statements

Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to a variety of matters, without limitation, including the expected future production capacity at GND, expected operational efficiencies of the debottlenecking project, the ability to capture and sequester additional carbon following the debottlenecking and other statements that are not purely statements of historical fact. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Gevo and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Gevo undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Gevo believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Gevo in general, see the risk disclosures in the Annual Report on Form 10-K of Gevo for the year ended December 31, 2025, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the U.S. Securities and Exchange Commission by Gevo.

Media Contact
Communications@gevo.com

IR Contact
IR@Gevo.com

BOCA RATON, Fla., Sept. 14, 2026 (GLOBE NEWSWIRE) — ADT Inc. (NYSE: ADT), the trusted leader in smart home security solutions, today announced that ADT Blu, a do-it-yourself (DIY) solution, is available for purchase on Walmart.com. This marks a milestone for ADT, expanding availability of its product offerings through a major retail channel and supporting the company’s focus on meeting customer needs in the DIY security market.

ADT Blu is a self-installed home security system that customers can set up quickly and manage directly through the ADT+ app. The fully integrated app allows customers to arm and disarm the system, view live video, and receive notifications when people, packages, animals, and vehicles are detected. Customers can also expand their system over time by adding devices as their needs evolve, from keeping an eye on routine activity like package deliveries to helping identify unexpected situations around the home. ADT Blu can be purchased without a long-term contract and installed without a technician visit. ADT Blu also provides customers with flexible monitoring options, allowing them to choose 24/7 professional monitoring through ADT’s company-owned and operated monitoring centers or to monitor their home themselves.

“Bringing ADT Blu to Walmart.com makes it easier for consumers nationwide to purchase a DIY security system that’s backed by a company with more than 150 years of experience in home security,” said Kim Miller, ADT’s Chief Marketing & Communications Officer. “Every new retail channel introduces ADT Blu to more consumers and expands access to a solution that offers flexibility and peace of mind.”

“We’re excited to add ADT to Walmart Marketplace as a recognizable and trusted brand in the security and smart home solutions industry,” said Tomas Ponce De Leon, Vice President, Walmart U.S. Seller Acquisition and Onboarding. “Having ADT make its products available on Walmart.com strengthens our assortment and gives customers a convenient way to shop a brand they already know and trust.”

ADT will continue pursuing additional retail channels to expand the availability of its DIY product line. In addition to Walmart.com, ADT Blu is available on ADT.com and by phone at 1-800-ADT-ASAP. Learn more about ADT Blu at ADT.com/Blu.

About ADT

ADT is a leading provider of security, interactive and smart home solutions serving residential and small business customers in the U.S. Through innovative offerings, unrivaled safety and a premium customer experience delivered by the largest network of smart home security professionals in the U.S., ADT empowers people to protect and connect to what matters most, every second, every day. For more information, visit ADT.com.

Media Contact: media@adt.com

Controlled-substance compliance and Schedule I manufacturing specialist brings experience in federal registration, controlled-substance operations, cGMP systems, quota administration, and DEA inspection readiness

Lakewood, CO, Sept. 14, 2026 (GLOBE NEWSWIRE) — KRTL Holding Group Inc. (OTC: KRTL) (“KRTL” or the “Company”) today announced that its wholly owned subsidiary, KRTL Biotech Inc., has appointed Justin Abril as President-Designate and Strategic Regulatory & API Consultant, adding specialized federal controlled-substance, pharmaceutical manufacturing, DEA regulatory, and FDA quality-system experience to KRTL Biotech’s leadership team.

Abril’s appointment expands KRTL Biotech’s regulatory and operational capabilities as the Company advances pharmaceutical API, botanical-drug, controlled-substance research, international sourcing, manufacturing-partner qualification, and regulatory consulting initiatives.

A Track Record in Federal Controlled-Substance Compliance
Abril is a federal controlled-substance compliance specialist with more than a decade of experience in Schedule I botanical-drug manufacturing, DEA regulatory affairs, and pharmaceutical quality systems. He is also Co-Founder and Principal of Vatic Advisors, a federal regulatory advisory practice serving manufacturers and operators in the controlled-substance and pharmaceutical sectors.

Serving as primary DEA liaison, Abril secured a federal Schedule I bulk manufacturer registration for marihuana, which his professional biography identifies as one of only seven such registrations issued nationally at that time. His responsibilities extended beyond registration and included development of the operational, security, procedural, and quality infrastructure required for a federally regulated controlled-substance manufacturing environment.

• Developed compliant facility and physical-security infrastructure under 21 CFR § 1301.72.

• Authored more than 60 controlled-substance standard operating procedures.

• Established cGMP quality systems under 21 CFR Parts 210 and 211.

• Managed ongoing ARCOS inventory reporting and annual DEA quota applications.

• Supported Investigational New Drug activities in compliance, sourcing, and agent capacities.

• Managed Schedule I exports from the United States to Canada and Europe.

• Successfully supported seven consecutive DEA audits and federal inspections.

• Holds the Certified Compliance and Ethics Professional (CCEP) credential.

Abril also brings approximately a decade of law-enforcement experience, including service as a Police Sergeant with the Department of Defense. His background includes command responsibility for more than 45 military and law-enforcement personnel and training of more than 150 officers.

Bringing Regulatory Execution to KRTL Biotech
Abril will work with management and outside specialists on regulatory strategy, facility and partner qualification, DEA matters, FDA quality systems, API/CMC development, controlled-substance compliance, research collaborations, pharmaceutical manufacturing relationships, and commercialization planning.

“Justin brings practical experience across federal controlled-substance compliance, pharmaceutical quality systems, DEA reporting, quotas, and inspection readiness,” said Cesar Herrera, Chief Executive Officer of KRTL Biotech Inc. “That experience is directly relevant to the pharmaceutical, API, research, and partner-qualification initiatives we are developing.”

Herrera continued, “Our objective is to build the regulatory and operational infrastructure required to evaluate opportunities properly, qualify facilities and partners, identify the correct development pathway, and determine whether a program can realistically advance toward pharmaceutical development and commercialization.”

Expanding KRTL Biotech’s Regulatory Consulting Capabilities
In addition to supporting KRTL’s internal pharmaceutical and development programs, the Company intends to build KRTL Biotech’s internal regulatory, quality, and supply-chain capabilities and to apply them as such programs advance. As these capabilities mature, the Company expects to use them to evaluate and qualify suppliers, manufacturers, laboratories, and collaborators, and where appropriate, to support qualified third parties engaged in similar categories of pharmaceutical and controlled-substance activity that KRTL is developing.

The contemplated service line is expected to focus on regulatory strategy, registration readiness, facility and security readiness, controlled-substance SOP development, recordkeeping and inventory controls, quota considerations, import/export planning, inspection preparedness, supplier and facility qualification, research and manufacturing pathway assessment, and related pharmaceutical quality-system support.

KRTL expects Abril to help shape this consulting capability and support delivery of regulatory strategy, readiness, documentation, and compliance-planning services. Such services would be performed within the scope of applicable law and would not constitute a guarantee of any DEA registration, quota, permit, FDA approval, or other governmental authorization.

Leadership and Equity Alignment
Under his agreement with KRTL Biotech, Abril will initially serve as Strategic Regulatory & API Consultant and President-Designate. In connection with the appointment, Abril will receive an equity incentive award consisting of 1,000,000 restricted shares of KRTL Holding Group Inc. common stock, subject to vesting, corporate approvals, securities-law requirements, and the terms of the definitive agreement and award documentation.

Upon achievement of a defined Compensation Event, which includes specified funding, collected commercial-revenue, or Board-approved financial-capacity milestones, Abril is expected to transition to salaried employment as President of KRTL Biotech Inc. and become eligible for an additional preferred-equity award, subject to the agreement’s terms and applicable corporate and securities-law requirements.

The Compensation Event is a financial-capacity milestone, not a financing commitment, revenue forecast, or guarantee that any threshold will be met.

About KRTL Biotech Inc.
KRTL Biotech Inc. is a wholly owned subsidiary of KRTL Holding Group Inc. focused on pharmaceutical, biotechnology, active pharmaceutical ingredient (API), botanical, regulatory, research, and commercialization opportunities in the United States and international markets. KRTL Biotech maintains federal registrations and entity identifiers with the U.S. Food and Drug Administration and SAM.gov, including SAM.gov UEI ULPJWZWBM9L5 and CAGE Code 109P9. These registrations and identifiers support the Company’s developing pharmaceutical, regulatory, research, government-contracting, and commercialization activities and do not, by themselves, constitute FDA approval of any specific product, DEA authority, or authorization for any specific controlled-substance activity.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include statements regarding anticipated executive roles, pharmaceutical and API strategies, controlled substance and psychedelic research initiatives, regulatory activities, partner qualification, research collaborations, manufacturing relationships, import/export pathways, financing, commercialization, and future operations. Forward-looking statements involve risks and uncertainties, and actual results may differ materially from those expressed or implied. There can be no assurance that contemplated regulatory registrations, permits, quotas, research approvals, import/export authorizations, manufacturing arrangements, institutional collaborations, pharmaceutical development programs, financing, or commercialization activities will be obtained or completed. Abril’s appointment itself does not provide KRTL with a DEA registration, FDA approval, controlled-substance quota, import/export authorization, or regulatory approval for any particular pharmaceutical product, compound, research program, or controlled activity.

CONTACT: www.krtlholding.com
info@krtlholding.com

Contact: 855-KRTL-HLD


www.krtlbiotech.com
info@krtlbiotech.com

www.krtl-icc.com
info@krtl-icc.com

News Summary:

• The NVIDIA CUDA-Q platform now includes the CUDA-Q Logical orchestration layer, giving the quantum industry an open, programmable way to design and test fault-tolerant quantum computing applications in areas such as drug discovery, financial modeling and materials development.
• Fermilab used CUDA-Q Logical to accelerate fault-tolerant architecture development from five months to three weeks — a 7x speedup.
• QUOPS is a benchmark for the future of quantum computing, measuring the readiness of fault-tolerant quantum hardware for practical applications. Developed by Sandia National Laboratories, QUOPS is now available in NVIDIA CUDA-Q.

TORONTO, Sept. 14, 2026 (GLOBE NEWSWIRE) — NVIDIA today announced an expansion of the NVIDIA CUDA-Q™ open source platform with CUDA-Q Logical, an orchestration layer that provides a programmable, verifiable approach to developing useful applications for fault-tolerant quantum computers.

Fault-tolerant quantum processors with logical qubits are essential for useful quantum computing, allowing systems to overcome the errors inherent in physical qubits so they can execute the larger computations needed for practical applications such as drug discovery, financial modeling and materials development.

However, developing applications for such systems is a tedious, time-consuming codesign challenge: A change to an algorithm, error-correction code, hardware architecture or other QPU component can significantly change the resources needed to run any given application.

With CUDA-Q Logical, researchers can now design and orchestrate the many components required for fault-tolerant quantum computing applications, easily switching between options to identify optimal system configurations for performance with logical qubits.

“Quantum computing is maturing into an era of logical qubits, and researchers need an open, customizable platform capable of representing all aspects of a fault-tolerant system,” said Timothy Costa, vice president and general manager of quantum at NVIDIA. “The addition of CUDA-Q Logical provides power and flexibility to explore fully integrated, co-optimized systems regardless of qubit type and architecture — drastically shortening the timeline to useful quantum-GPU supercomputing.”

CUDA-Q Logical is already being used by QPU makers and labs including Fermi National Accelerator Laboratory, Infleqtion, IQM Quantum Computers, QCDesign Quantum Motion and Sandia National Laboratories.

Using CUDA-Q Logical, Iceberg Quantum modeled its fault-tolerant architecture for Diraq’s qubits, showing how 1,000 logical qubits can be created with just 150,000 physical qubits, roughly 10x fewer than Diraq’s previous estimates. CUDA-Q Logical gave an unprecedented way to rapidly assess potential implementations of Iceberg’s architecture, helping dramatically reduce the hardware needed for useful, fault-tolerant quantum computing.

Fermilab Uses CUDA-Q Logical to Explore Fault-Tolerant Applications
In early work, Fermilab researchers used CUDA-Q Logical to validate prior results and evaluate physical qubits, runtimes and other resource requirements across different error-correction approaches and quantum hardware.

Fermilab transformed complicated fault-tolerant system designs into a repeatable and verifiable computational workflow, accelerating fault-tolerant algorithm development from five months to three weeks, a 7x speedup.

“Fault-tolerant quantum computing is the path to unlocking new scientific discovery, but getting there will require researchers to codesign algorithm, error correction, architectures and hardware together,” said Anna Grassellino, chief technology officer at Fermilab and director of the Superconducting Quantum Materials and Systems Center. “Using CUDA-Q Logical, our team explored combinations of these resources in just three weeks, compared with what would have typically taken about five months of building specialized infrastructure.”

Sandia Creates Benchmark for Future of Quantum Computing
QUOPS is a new, independent cross-platform benchmark developed by Sandia National Laboratories that measures the progress quantum computing systems are making toward utility-scale applications.

With Sandia’s QUOPS, the industry now has access to a hardware-agnostic, open method to benchmark progress toward shared goals for fault-tolerant quantum computers. Historically, progress in quantum computing has been measured primarily through advances in physical qubits — increasing qubit counts, improving fidelity and extending coherence.

“At Sandia, we can’t wait to see fault-tolerant quantum computers helping to solve problems of national importance for the Department of Energy and the United States,” said Timothy Proctor, co-director of Sandia National Laboratories’ Quantum Performance Laboratory. “Our mission right now is to bring that about sooner, by accelerating our industry partners’ progress. To do that, we, and other quantum computing stakeholders, have to be able to track and forecast the growth of quantum computer abilities. We created QUOPS to do exactly that, and we’re excited to see it used by quantum computing vendors and customers.”

Sandia shared early results in a preprint posted ahead of IEEE Quantum Week, reporting initial QUOPS benchmarks for QPUs from Google, IBM and Quantinuum. A QUOPS reference implementation is available in NVIDIA CUDA-Q.

Expanding the Quantum-GPU Supercomputing Platform
The ecosystem is also adopting NVIDIA’s larger lineup of quantum computing technologies for turning qubits into useful quantum-GPU supercomputers.

Diraq used NVIDIA Ising, the world’s first family of open models for building and deploying AI for useful quantum computing, to calibrate its silicon-based qubit processor.

Companies are integrating their quantum processors with GPU supercomputing using NVIDIA NVQLink™, the open system architecture for tightly coupling quantum processors with GPU supercomputers. With NVQLink:

• Anyon Computing developed a new quantum control system.
• Quandela developed a QPU-GPU architecture.
• Quantum Machines ran a demo of integrating state-of-the-art supercomputing resources with qubits at the Israeli Quantum Computing Center.

The NVIDIA CUDA-Q open development platform continues to be adopted across the quantum computing ecosystem:

• BlueQubit launched the Quantum Flywheel grant program for researchers, to give them access to NVIDIA accelerated computing through CUDA-Q.
• Qedma Quantum Computing and QCentroid each integrated their technology with CUDA-Q to support quantum error correction and mitigation, as well as the deployment of quantum applications.

The quantum ecosystem is also working with NVIDIA to develop new and improved quantum applications:

• IonQ announced progress on DQAOA-GPT, a quantum generative AI framework, using NVIDIA accelerated computing.
• MITRE published work on building GPU-accelerated digital twins of quantum sensors.
• Phasecraft is using NVIDIA cuQuantum to generate the largest-known variational quantum eigensolver emulated molecular database.
• UCLA and Caltech are advancing the design of control sequences needed to run quantum applications.

Availability
CUDA-Q Logical is now available through GitHub. Explore the QUOPS repository.

Learn more by reading these papers on CUDA-Q Logical and QUOPS.

About NVIDIA
NVIDIA (NASDAQ: NVDA) is the world leader in AI and accelerated computing. 

For further information, contact:
Aaron Groff
Corporate Communications
NVIDIA Corporation
press@nvidia.com

Certain statements in this press release including, but not limited to, statements as to: expectations with respect to quantum computing; expectations with respect to growth, performance, availability, and benefits of NVIDIA’s products, services and technologies, and related trends and drivers; expectations with respect to NVIDIA’s third party arrangements, including with its collaborators and partners; expectations with respect to technology developments, and related trends and drivers; projected market growth and trends; expectations with respect to AI and related industries; and other statements that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the “safe harbor” created by those sections based on management’s beliefs and assumptions and on information currently available to management and are subject to risks and uncertainties that could cause results to be materially different than expectations. Important factors that could cause actual results to differ materially include: global economic and political conditions; NVIDIA’s reliance on third parties to manufacture, assemble, package and test NVIDIA’s products; the impact of technological development and competition; development of new products and technologies or enhancements to NVIDIA’s existing products and technologies; market acceptance of NVIDIA’s products or NVIDIA’s partners’ products; design, manufacturing or software defects; changes in consumer preferences or demands; changes in industry standards and interfaces; unexpected loss of performance of NVIDIA’s products or technologies when integrated into systems; NVIDIA’s ability to realize the potential benefits of business investments or acquisitions; and changes in applicable laws and regulations, as well as other factors detailed from time to time in the most recent reports NVIDIA files with the Securities and Exchange Commission, or SEC, including, but not limited to, its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Copies of reports filed with the SEC are posted on NVIDIA’s website and are available from NVIDIA without charge. These forward-looking statements are not guarantees of future performance and speak only as of the date hereof, and, except as required by law, NVIDIA disclaims any obligation to update these forward-looking statements to reflect future events or circumstances.

© 2026 NVIDIA Corporation. All rights reserved. NVIDIA, the NVIDIA logo, and other NVIDIA product and service names are trademarks and/or registered trademarks of NVIDIA Corporation in the U.S. and other countries and regions. Other company, product, and service names may be trademarks of the respective companies with which they are associated.

A photo accompanying this announcement is available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/0f02bc26-1063-45ff-85fe-7d84a32d9392

Building an Integrated, Compliance-First Financial Infrastructure Platform

HONG KONG, Sept. 14, 2026 (GLOBE NEWSWIRE) — SOLOWIN HOLDINGS (Nasdaq: AXG) (together with its subsidiaries, “AXG” or the “Company”), a leading financial technology firm bridging traditional and digital assets, today provided an update on its strategy to build a regulated, AI-native financial infrastructure platform.

AXG is advancing three core technology pillars – regulated digital assets, high-performance AI computing and quantum-enhanced financial modeling – with the goal of creating a single ecosystem for payments, tokenization, wealth management and institutional financial services.

The Company’s recent milestones include:

• A full stablecoin issuance license through AX Coin Bahrain B.S.C. (c), issued by the Central Bank of Bahrain, together with Sharia-compliant stablecoin certification.
• The launch of AXG Digital, targeting more than 100 MW of operational AI and high-performance computing capacity by 2028, with a development pipeline exceeding 1 GW of potential capacity.
• Expansion of AXG’s AI technology stack through KOVAR and the AGENPAY initiative for intelligent, agent-driven payments.
• A new non-binding Memorandum of Understanding (the “MOU”) with EvolveQ Limited (“EvolveQ”) to explore quantum-powered financial optimization using AI, high-performance computing (HPC) and quantum computing.

A Decade of Compliance-First Growth

Tracing its operating history to 2016, AXG has expanded from traditional financial services into a broader regulated digital finance platform. The Company obtained Hong Kong Securities and Futures Commission licenses, listed on Nasdaq in 2023 and completed its virtual-asset business upgrade in 2024.

In 2025, AXG acquired AlloyX Limited, expanding its capabilities in tokenized money-market funds and cross-border payments. In 2026, subsidiary AX Coin Bahrain B.S.C. (c) secured a full stablecoin issuance license from the Central Bank of Bahrain and obtained Sharia-compliant stablecoin certification.

AI Infrastructure: 100+ MW Target and 1 GW+ Pipeline

In August 2026, AXG launched AXG Digital, its dedicated AI and HPC infrastructure division headquartered in Utah, USA. AXG Digital is targeting more than 100 MW of operational capacity by 2028 and has a development pipeline exceeding 1 GW of potential capacity across Europe, the United States and sub-Arctic markets.

AXG’s AI stack includes KOVAR AI, an enterprise LLM gateway; KOVAR Cloud; KOVAR Router, an institutional unified API designed for millisecond-level intelligent routing; and KOVAR KYA, a Know Your Agent identity and compliance solution.

In April 2026, AXG signed an MOU with SC Ventures, Standard Chartered’s innovation arm, to co-develop AGENPAY, an initiative focused on intelligent payment routing and API retrieval for agent-driven payments.

Quantum Computing: Expanding Financial Optimization

In September 2026, AlloyX (Hong Kong) Limited, an indirect wholly owned subsidiary of AXG, entered into a non-binding MOU with EvolveQ to explore the integration of quantum computing, AI and HPC for financial and digital-asset applications.

The proposed collaboration is focused on two areas: developing next-generation AI wealth-management infrastructure and FinQ-based models for quantum-powered cross-asset and portfolio optimization.

EvolveQ plans to coordinate quantum, HPC and AI/GPU resources to convert complex financial constraints into executable computational tasks and advanced financial models.

Mr. Frank Chen, Managing Director of AlloyX, said: “By combining AXG’s AI infrastructure and intelligent routing capabilities with EvolveQ’s quantum orchestration technology, we aim to create powerful new tools for institutional finance, trading and agent-driven payments.”

Dr. Lumos Yue, Chief Technology Officer of EvolveQ, said: “Working with AXG gives us the opportunity to bring FinQ quantum orchestration into a regulated institutional ecosystem and explore how quantum, HPC and AI can work together to solve increasingly complex financial problems.”

One Integrated Ecosystem

AXG is building an end-to-end ecosystem designed to connect regulated finance with digital assets and AI:

• AXCOIN – regulated stablecoin issuance and agentic payments
• AXONE – global stablecoin treasury management
• FERION – real-world asset tokenization
• KOVAR – AI infrastructure, agent identity and global AI Token Router
• AgentX – AI-driven wealth management
• Solomon JFZ – Hong Kong virtual-asset-upgraded investment banking platform

Mr. Peter Lok, Chairman and Chief Executive Officer of AXG, commented: “AXG is bringing regulated digital assets, AI infrastructure and advanced computing together on one platform. Our strategy is built around a simple goal: make regulated digital value more useful, programmable and accessible 24/7 across borders, institutions and intelligent systems. That is the foundation of our mission – Mobilizing Tokens 24/7.”

About SOLOWIN HOLDINGS

SOLOWIN HOLDINGS (Nasdaq: AXG) is a leading global regulated fintech company. Established in 2016, AXG combines blockchain and artificial intelligence technologies to operate a fully compliant dual-token digital economy super platform.

Guided by the mission “Mobilizing Tokens 24/7,” the Company operates two core business pillars: Digital Asset Tokens and AI Tokens. Its offerings span stablecoin issuance and payments, asset tokenization, securities trading and asset management, as well as AI-powered services including cloud infrastructure, Know-Your-Agent verification, and token router.

Through its integrated ecosystem, including AX COIN, AX ONE, FERION, Solomon JFZ, AgentX, and KOVAR, AXG empowers global institutions and investors to capitalize on the rapid growth of the dual-token economy.

For more information, visit www.alloyx.com and follow us on LinkedIn at AXG (Solowin Holdings).

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. The Company has attempted to identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “potential,” “continue” or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations that arise after the date hereof, except as may be required by law. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and other factors discussed in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”) including the “Risk Factors” section of the Company’s most recent Annual Report on Form 20-F as well as in its other reports filed or furnished from time to time with the SEC. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s filings with the SEC, which are available for review at www.sec.gov.

For investor and media inquiries, please contact:

SOLOWIN HOLDINGS
Investor Relations Department
Email: ir@solowin.io

Ascent Investor Relations LLC 
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com